Intradiscal Therapies for Lumbar Degenerative Disk Disease.
Journal
The Journal of the American Academy of Orthopaedic Surgeons
ISSN: 1940-5480
Titre abrégé: J Am Acad Orthop Surg
Pays: United States
ID NLM: 9417468
Informations de publication
Date de publication:
01 Sep 2022
01 Sep 2022
Historique:
received:
08
12
2021
accepted:
23
02
2022
entrez:
19
8
2022
pubmed:
20
8
2022
medline:
23
8
2022
Statut:
ppublish
Résumé
Discogenic low back pain is a common musculoskeletal complaint in patients presenting to orthopaedic surgeons. In addition to surgical options, there are several nonsurgical intradiscal treatments that have gained interest, ranging from biologic, nonbiologic, cell-based, and molecular therapies. However, there is limited evidence for many of these techniques, and some are still in the clinical trial stage. We describe a broad overview of these intradiscal therapies, the mechanism of action, and the evidence behind them.
Identifiants
pubmed: 35984081
doi: 10.5435/JAAOS-D-21-01155
pii: 00124635-202209010-00007
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1084-e1094Informations de copyright
Copyright © 2022 by the American Academy of Orthopaedic Surgeons.
Références
Hurwitz EL, Randhawa K, Yu H, Côté P, Haldeman S: The Global Spine Care Initiative: A summary of the global burden of low back and neck pain studies. Eur Spine J 2018;27:796-801.
Maitre CLL, Dahia CL, Giers M, et al.: Development of a standardized histopathology scoring system for human intervertebral disc degeneration: An Orthopaedic Research Society Spine Section Initiative. JOR Spine 2021;4:e1167.
Fujii K, Yamazaki M, Kang JD, et al.: Discogenic back pain: Literature review of definition, diagnosis, and treatment. JBMR Plus 2019;3:e10180.
Wu TJ, Hung CY, Lee CW, Lam S, Clark TB, Chang KV: Ultrasound-guided lumbar intradiscal injection for discogenic pain: Technical innovation and presentation of two cases. J Pain Res 2020;13:1103-1107.
Kepler CK, Anderson GD, Tannoury C, Ponnappan RK: Intervertebral disk degeneration and emerging biologic treatments. Am Acad Orthop Surg 2011;19:543-553.
Helm Ii S, Simopoulos TT, Stojanovic M, Abdi S, Terany MAE: Effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician 2017;20:447-470.
Kapural L: Intradiscal annuloplasty for the treatment of discogenic pain, in Deer T, Leong M, Buvanendran A, Kim P, Panchal S, eds: Treatment of Chronic Pain by Interventional Approaches. Berlin, Heidelberg, Springer, 2014, pp 297-305.
Gelalis I, Gkiatas I, Spiliotis A, et al.: Current concepts in intradiscal percutaneous minimally invasive procedures for chronic low back pain. Asian J Neurosurg 2019;14:657.
Chen Y, Tang T, Erdek MA: Advanced image-guided procedures for painful spine. Neuroimag Clin N Am 2019;29:553-561.
Breemer MC, Malessy MJA, Notenboom RG: Origin, branching pattern, foraminal and intraspinal distribution of the human lumbar sinuvertebral nerves. Spine J 2022;22:472-482.
Lotz JC, Fields AJ, Liebenberg EC: The role of the vertebral end plate in low back pain. Global Spine J 2013;3:153-164.
Fischgrund JS, Rhyne A, Franke J, et al.: Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: A prospective randomized double-blind sham-controlled multi-center study. Eur Spine J 2018;27:1146-1156.
Fischgrund JS, Rhyne A, Macadaeg K, et al.: Long-term outcomes following intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 5-year treatment arm results from a prospective randomized double-blind sham-controlled multi-center study. Eur Spine J 2020;29:1925-1934.
Khalil JG, Smuck M, Koreckij T, et al.: A prospective, randomized, multicenter study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain. Spine J 2019;19:1620-1632.
Rasouli MR, Rahimi-Movaghar V, Shokraneh F, Moradi-Lakeh M, Chou R: Minimally invasive discectomy versus microdiscectomy/open discectomy for symptomatic lumbar disc herniation. Cochrane Database Syst Rev 2014;9:CD010328.
Bokov A, Skorodumov A, Isrelov A, Stupak Y, Kukarin A: Differential treatment of nerve root compression pain caused by lumbar disc herniation applying nucleoplasty. Pain Physician 2010;13:469-480.
Nguyen C, Boutron I, Baron G, et al.: Intradiscal glucocorticoid injection for patients with chronic low back pain associated with active discopathy: A randomized trial. Ann Intern Med 2017;166:547.
Wilkinson HA, Schuman N: Intradiscal corticosteroids in the treatment of lumbar and cervical disc problems. Spine 1980;5:385-389.
Tavares I, Thomas E, Cyteval C, et al.: Intradiscal glucocorticoids injection in chronic low back pain with active discopathy: A randomized controlled study. Ann Phys Rehabil Med 2021;64:101396.
La Torre D, Volpentesta G, Stroscio C, et al.: Percutaneous intradiscal injection of radiopaque gelified ethanol: Short- and long-term functional outcome and complication rate in a consecutive series of patients with lumbar disc herniation. Br J Pain 2021;15:234-241.
Hashemi M, Dadkhah P, Taheri M, Katibeh P, Asadi S: Effectiveness of intradiscal injection of radiopaque gelified ethanol (DiscoGel) versus percutaneous laser disc decompression in patients with chronic radicular low back pain. Korean J Pain 2020;33:66-72.
Papadopoulos D, Batistaki C, Kostopanagiotou G: Comparison of the efficacy between intradiscal gelified ethanol (Discogel) injection and intradiscal combination of pulsed radiofrequency and gelified ethanol (Discogel) injection for chronic discogenic low back pain treatment. A randomized double-blind clinical study. Pain Med 2020;21:2713-2718.
Ercalik T, Kilic M: Efficacy of intradiscal ozone therapy with or without periforaminal steroid injection on lumbar disc herniation: A double-blinded controlled study. Pain Physician 2020;23:477-484.
Costa T, Linhares D, da Silva MR, Neves N: Ozone therapy for low back pain. A systematic review. Acta Reumatol Port 2018;43:172-181.
Chang JDS, Lu HS, Chang YF, Wang D: Ameliorative effect of ozone on cytokine production in mice injected with human rheumatoid arthritis synovial fibroblast cells. Rheumatol Int 2005;26:142-151.
Iliakis E, Valadakis V, Vynios DH, Tsiganos CP, Agapitos E: Rationalization of the activity of medical ozone on intervertebral disc A histological and biochemical study. Neuroradiol J 2001;14:23-30.
Shankar H, Scarlett JA, Abram SE: Anatomy and pathophysiology of intervertebral disc disease. Tech Reg Anesth Pain Manag 2009;13:67-75.
Vadalà G, Ambrosio L, Russo F, Papalia R, Denaro V: Interaction between mesenchymal stem cells and intervertebral disc microenvironment: From cell therapy to tissue engineering. Stem Cells Int 2019;2019:1-15.
Caplan AI: New era of cell-based orthopedic therapies. Tissue Eng Part B Rev 2009;15:195-200.
Vadalà G, Russo F, Ambrosio L, Loppini M, Denaro V: Stem cells sources for intervertebral disc regeneration. World J Stem Cells 2016;8:185.
Schroeder J, Kueper J, Leon K, Liebergall M: Stem cells for spine surgery. World J Stem Cells 2015;7:186.
Vadalà G, Ambrosio L, Russo F, Papalia R, Denaro V: Stem cells and intervertebral disc regeneration overview—What they can and can't do. Int J Spine Surg 2021;15:40-53.
Noriega DC, Ardura F, Hernández-Ramajo R, et al.: Treatment of degenerative disc disease with allogeneic mesenchymal stem cells: Long-term follow-up results. Transplantation 2021;105:e25-e27.
Amirdelfan K, Bae H, McJunkin T, et al.: Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: A prospective randomized, placebo-controlled 36-month study of safety and efficacy. Spine J 2021;21:212-230.
Barakat AH, Elwell VA, Lam KS: Stem cell therapy in discogenic back pain. J Spine Surg 2019;5:561-583.
Mochida J, Sakai D, Nakamura Y, Watanabe T, Yamamoto Y, Kato S: Intervertebral disc repair with activated nucleus pulposus cell transplantation: A three-year, prospective clinical study of its safety. Eur Cells Mater 2015;29:202-212.
Navani A, Manchikanti L, Albers SL, et al.: Responsible, safe, and effective use of biologics in the management of low back pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician 2019;22:S1-S74.
Matta A, Erwin WM: Injectable biologics for the treatment of degenerative disc disease. Curr Rev Musculoskelet Med 2020;13:680-687.
Hirase T, Jack Ii RA, Sochacki KR, et al.: Systemic review: Is an intradiscal injection of platelet-rich plasma for lumbar disc degeneration effective? Cureus J Med Sci 2020;12:e8831.
Prysak MH, Lutz CG, Zukofsky TA, Katz JM, Everts PA, Lutz GE: Optimizing the safety of intradiscal platelet-rich plasma: An in vitro study with Cutibacterium acnes. Regen Med 2019;14:955-967.
Cheng J, Santiago KA, Nguyen JT, Solomon JL, Lutz GE: Treatment of symptomatic degenerative intervertebral discs with autologous platelet-rich plasma: Follow-up at 5-9 years. Regen Med 2019;14:831-840.
Hodgkinson T, Shen B, Diwan A, Hoyland JA, Richardson SM: Therapeutic potential of growth differentiation factors in the treatment of degenerative disc diseases. JOR Spine 2019;2:e1045.
Peeters M, Detiger SEL, Karfeld-Sulzer LS, et al.: BMP-2 and BMP-2/7 heterodimers conjugated to a fibrin/hyaluronic acid hydrogel in a large animal model of mild intervertebral disc degeneration. Bioresearch Open Access 2015;4:398-406.
Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K: Neurologic impairment from ectopic bone in the lumbar canal: A potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2008;8:1011-1018.
Walsh AJL, Bradford DS, Lotz JC: In vivo growth factor treatment of degenerated intervertebral discs. Spine 2004;29:156-163.
Yan J, Yang S, Sun H, et al.: Effects of releasing recombinant human growth and differentiation factor-5 from poly(lactic-co-glycolic acid) microspheres for repair of the rat degenerated intervertebral disc. J Biomater Appl 2014;29:72-80.
Pereira DR, Silva-Correia J, Oliveira JM, Reis RL: Hydrogels in acellular and cellular strategies for intervertebral disc regeneration. J Tissue Eng Regen M 2013;7:85-98.
Moriguchi Y, Alimi M, Khair T, et al.: Biological treatment approaches for degenerative disk disease: A literature review of in vivo animal and clinical data. Global Spine J 2016;6:497-518.
Xia K, Zhu J, Hua J, et al.: Intradiscal injection of induced pluripotent stem cell-derived nucleus pulposus-like cell-seeded polymeric microspheres promotes rat disc regeneration. Stem Cells Int 2019;2019:1-14.
Yin W, Pauza K, Olan WJ, Doerzbacher JF, Thorne KJ: Intradiscal injection of fibrin sealant for the treatment of symptomatic lumbar internal disc disruption: Results of a prospective multicenter pilot study with 24-month follow-up. Pain Med 2014;15:16-31.
Lee CS, Bishop ES, Zhang R, et al.: Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes Dis 2017;4:43-63.
Ju DG, Kanim LE, Bae HW: Intervertebral disc repair: Current concepts. Global Spine J 2020;10:130S-136S.
Farhang N, Ginley-Hidinger M, Berrett KC, Gertz J, Lawrence B, Bowles RD: Lentiviral CRISPR epigenome editing of inflammatory receptors as a gene therapy strategy for disc degeneration. Hum Gene Ther 2019;30:1161-1175.
Wallach CJ, Kim JS, Sobajima S, et al.: Safety assessment of intradiscal gene transfer: A pilot study. Spine J 2006;6:107-112.
Schmelz M, Mantyh P, Malfait AM, et al.: Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: Mechanism of action in the context of efficacy and safety. Pain 2019;160:2210-2220.
Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV, Anderson DG: The molecular basis of intervertebral disc degeneration. Spine J 2013;13:318-330.
Freemont AJ, Watkins A, Maitre CL, et al.: Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol 2002;197:286-292.
Markman JD, Bolash RB, McAlindon TE, et al.: Tanezumab for chronic low back pain: A randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety. Pain 2020;161:2068-2078.
Risbud MV, Shapiro IM: Role of cytokines in intervertebral disc degeneration: Pain and disc content. Nat Rev Rheumatol 2014;10:44-56.
Sousa-Valente J, Brain SD: A historical perspective on the role of sensory nerves in neurogenic inflammation. Semin Immunopathol 2018;40:229-236.
Inage K, Orita S, Yamauchi K, et al.: Dose optimization for single intradiscal administration of the tumor necrosis factor-α inhibitor, etanercept, in rat disc injury models. Asian Spine J 2016;10:619-623.
Norimoto M, Ohtori S, Yamashita M, et al.: Direct application of the TNF-alpha inhibitor, etanercept, does not affect CGRP expression and phenotypic change of DRG neurons following application of nucleus pulposus onto injured sciatic nerves in rats. Spine 2008;33:2403-2408.
Koerner JD, Markova DZ, Schroeder GD, et al.: The effect of substance P on an intervertebral disc rat organ culture model. Spine 2016;41:1851-1859.
Kepler CK, Markova DZ, Koerner JD, et al.: Substance P receptor antagonist suppresses inflammatory cytokine expression in human disc cells. Spine 2015;40:1261-1269.
Canseco JA, Markova DZ, Chang M, Kepler CK: The role of CGRP as a potential therapeutic target for discogenic back pain [Abstract]. In: Annual Meeting of the Orthopaedic Research Society ; February 8-11, 2020; Phoenix, AZ. Abstract No. 2474.
Hartvigsen J, Hancock MJ, Kongsted A, et al.: What low back pain is and why we need to pay attention. Lancet 2018;391:2356-2367.
Shayota B, Wong TL, Fru D, et al.: A comprehensive review of the sinuvertebral nerve with clinical applications. Anat Cell Biol 2019;52:128-133.